Leverage Partners Absolute Return Fund Spc Bausch Health Companies Inc. Transaction History

Leverage Partners Absolute Return Fund Spc

$76.9 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 05, 2022	SELL	$7.06 - $23.63 $353,000 - $1.18 Million	-50,000 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$21.6 - $27.79 $1.08 Million - $1.39 Million	50,000 New	50,000 $1.14 Million

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$261 Million
2.88% of portfolio
Goldentree Asset Management LP New York, NY

29.4M
Shares

$221 Million
21.8% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$199 Million
14.7% of portfolio
National Bank Of Canada

15.6M
Shares

$118 Million
0.18% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$97.9 Million
0.26% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leverage Partners Absolute Return Fund Spc, based on Form 13F filings with the SEC.

News

Stay updated on Leverage Partners Absolute Return Fund Spc with notifications on news.

Account